Exclusively-natural psychedelics company specializing in drug discovery and extraction to treat mental health condition through psychedelics medicines Filament Health Corp. (NEO: FH) (OTCMKTS: FLHLF) announced having received a notification from Financial Regulatory Authority (FRA) indicating that its shares have qualified to commence trading on the OTC Pink Market in the united States.
Share of Filament Health will commence trading in the OTC markets under the ticker symbol ‘FLHLF’. The company further said that it has submitted an application for uplisting its shares to the OTCQB Venture Market.
In addition the company has also applied to the Depository Trust Company (DTC) for DTC eligibility. This will significantly simplify the process of trading the common shares of Filament Health.
DTC is a subsidiary of the Depository Trust & Clearing Corporation and it’s in charge of managing the electronic clearance and settlement of publicly traded companies.
“We are pleased to have initiated our listing process on the OTCQB. This listing will enhance our visibility and allow Filament’s common shares to be more available to a broad range of institutional and retail investors in the United States,” said the company’s CEO, Benjamin Lightburn.